Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Pricing
Podcast Image

Body of Wonder

Episode #12 Adaptogens for Stress Resiliency and Immunity with Dr. Lise Alschuler

19 Nov 2020

Description

Adaptogens are a unique group of plants and mushrooms that helps to normalize the functions of the body. They are favorites among many herbalists, naturopaths, and integrative medicine practitioners as they’ve been clinically proven to help the body to cope with acute and long-term stress, boost immunity, and increase energy.  Highly regarded in traditional medicine they have been used for thousands of years in Chinese and Ayurvedic medicine. Our guest today is Dr. Lise Alschuler, a naturopathic doctor with board certification in naturopathic oncology. Lise is the Associate Director of the Fellowship in Integrative Medicine at the Andrew Weil Center for Integrative Medicine and a Professor of Clinical Medicine at the University of Arizona School of Medicine. She has co-authored two books, Definitive Guide to Cancer and Definitive Guide to Thriving After Cancer. Lise describes how adaptogens are natural regulators that can “balance” the body and bring it back to homeostasis. She describes the mechanism of action by which they work and which symptoms may benefit from adaptogens. Dr. Andrew Weil discusses how adaptogenic herbs, like ginseng, were first introduced to Western culture. Lise, Andy, and Victoria discuss why they use adaptogens in their daily routine and share their favorites. On this episode, we discuss; astragalus, ginseng, rhodiola, schisandra, reishi, ashwagandha, and holy basil (tulsi). Always consult your primary care provider before adding adaptogens or supplements to your diet or routine.

Audio
Featured in this Episode

No persons identified in this episode.

Transcription

This episode hasn't been transcribed yet

Help us prioritize this episode for transcription by upvoting it.

0 upvotes
🗳️ Sign in to Upvote

Popular episodes get transcribed faster

Comments

There are no comments yet.

Please log in to write the first comment.